-
Product Insights
B-Cell Non-Hodgkin Lymphoma: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma - Global Clinical Trials Review, 2026" provides an overview of B-Cell Non-Hodgkin Lymphoma Clinical trials scenario. This report provides top line data relating to the clinical trials on B-Cell Non-Hodgkin Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Head And Neck Squamous Cell Carcinoma (HNSC): Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Head And Neck Squamous Cell Carcinoma (HNSC) - Global Clinical Trials Review, 2026" provides an overview of Head And Neck Squamous Cell Carcinoma (HNSC) Clinical trials scenario. This report provides top line data relating to the clinical trials on Head And Neck Squamous Cell Carcinoma (HNSC) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country...
-
Product Insights
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2026" provides an overview of Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) Clinical trials scenario. This report provides top line data relating to the clinical trials on Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer). Report includes an overview of trial numbers and their average enrollment in top countries conducted...
-
Sector Analysis
Colorectal Cancer (CRC): Epidemiology Report and Forecast to 2035
Colorectal cancer (International Classification of Diseases, 10th Revision [ICD-10] code = C18–C20), also referred to as bowel cancer, is the cancer of the colon, rectum, or rectosigmoid junction. It is a type of gastrointestinal malignancy that originates from either the colon or the rectum. Although both forms can be defined as colon or rectal cancers, depending on their origin, they are often merged because of their many biologically and clinically common features (American Cancer Society, 2024b, 2024c, 2025). In 2024,...
-
Product Insights
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer): Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer) - Global Clinical Trials Review, 2026" provides an overview of Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer) Clinical trials scenario. This report provides top line data relating to the clinical trials on Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer). Report includes an overview of trial numbers and their average enrollment in top countries conducted...
-
Product Insights
Bile Duct Cancer (Cholangiocarcinoma): Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Bile Duct Cancer (Cholangiocarcinoma) - Global Clinical Trials Review, 2026" provides an overview of Bile Duct Cancer (Cholangiocarcinoma) Clinical trials scenario. This report provides top line data relating to the clinical trials on Bile Duct Cancer (Cholangiocarcinoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Squamous Non-Small Cell Lung Cancer: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Squamous Non-Small Cell Lung Cancer - Global Clinical Trials Review, 2026" provides an overview of Squamous Non-Small Cell Lung Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Squamous Non-Small Cell Lung Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Gastroesophageal (GE) Junction Carcinomas: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Gastroesophageal (GE) Junction Carcinomas - Global Clinical Trials Review, 2026" provides an overview of Gastroesophageal (GE) Junction Carcinomas Clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroesophageal (GE) Junction Carcinomas . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status...
-
Product Insights
Bladder Cancer: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Bladder Cancer - Global Clinical Trials Review, 2026" provides an overview of Bladder Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...